tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:tella Inc (2191) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9408
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen the attacking system against cancers. It also develops regenerative medicine and cell medicine for cancer. Tella provides operational support and consultation services. The company offers its therapy for contracted medical institutions in Japan. Tella is headquartered in Tokyo, Japan.

tella Inc (2191) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
tella Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
tella Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
OncoTherapy Science and Tella Enter into Co-Development Agreement 10
tella Enters into Research Agreement with Medical Corporation Isokai for Vaccell 11
Tella Enters into Research Agreement with Kitasato Institute 12
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 13
Equity Offering 14
tella Plans to Raise USD8.7 Million in Private Placement of Shares 14
Kohjin Bio Raises USD1.7 Million in Private Placement of Shares 15
Acquisition 16
tella Sells 44.4% Stake in Osaka-Based Cell Processing Facilities Consolidated Subsidiary for USD1 Million 16
tella Acquires Bioimmulance 17
tella Inc – Key Competitors 18
tella Inc – Key Employees 19
tella Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
tella Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Deals By Therapy Area, 2012 to YTD 2018 8
tella Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OncoTherapy Science and Tella Enter into Co-Development Agreement 10
tella Enters into Research Agreement with Medical Corporation Isokai for Vaccell 11
Tella Enters into Research Agreement with Kitasato Institute 12
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 13
tella Plans to Raise USD8.7 Million in Private Placement of Shares 14
Kohjin Bio Raises USD1.7 Million in Private Placement of Shares 15
tella Sells 44.4% Stake in Osaka-Based Cell Processing Facilities Consolidated Subsidiary for USD1 Million 16
tella Acquires Bioimmulance 17
tella Inc, Key Competitors 18
tella Inc, Key Employees 19

List of Figures
tella Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Vectura Group Plc (VEC)-医療機器分野:企業M&A・提携分析
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • LIC of India:企業の戦略・SWOT・財務分析
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Varta Microbattery GmbH:企業の戦略的SWOT分析
    Varta Microbattery GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Neurimmune Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a f …
  • Double Bond Pharmaceutical International AB (DBPB):製薬・医療:M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • Sarawak Energy Bhd:企業の戦略的SWOT分析
    Sarawak Energy Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Mitsubishi Gas Chemical Co Inc (4182):企業の財務・戦略的SWOT分析
    Mitsubishi Gas Chemical Co Inc (4182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • The NorInchukin Bank:企業の戦略・SWOT・財務情報
    The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The NorInchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Johnson Matthey Plc (JMAT):電力:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Neo Performance Materials Inc:企業の戦略・SWOT・財務分析
    Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report Summary Neo Performance Materials Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CellSeed Inc (7776):企業の財務・戦略的SWOT分析
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • Bright Horizons Family Solutions LLC (BFAM):企業の財務・戦略的SWOT分析
    Summary Bright Horizons Family Solutions LLC (Bright Horizons), subsidiary of Bright Horizons Capital Corp, is a provider of educational advisory services and child care services. It offers curriculum and programs including early education and preschool, back-up child and adult care programs, infant …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Teva Pharmaceutical Industries Ltd (TEVA)-製薬・医療分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • SAP SE:企業の戦略・SWOT・財務情報
    SAP SE - Strategy, SWOT and Corporate Finance Report Summary SAP SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Oil States International, Inc.:企業の戦略・SWOT・財務分析
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆